Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$314.68 - $395.94 $383,594 - $482,650
-1,219 Reduced 0.44%
273,241 $90 Million
Q1 2024

Apr 26, 2024

SELL
$338.27 - $413.0 $16.2 Million - $19.8 Million
-47,828 Reduced 14.84%
274,460 $109 Million
Q3 2023

Oct 27, 2023

BUY
$354.9 - $412.41 $893,283 - $1.04 Million
2,517 Added 0.79%
322,288 $121 Million
Q2 2023

Jul 28, 2023

SELL
$334.63 - $382.47 $3.51 Million - $4.01 Million
-10,494 Reduced 3.18%
319,771 $122 Million
Q1 2023

Apr 21, 2023

SELL
$232.5 - $346.47 $130,665 - $194,716
-562 Reduced 0.17%
330,265 $114 Million
Q4 2022

Feb 01, 2023

BUY
$209.34 - $261.61 $69.3 Million - $86.5 Million
330,827 New
330,827 $77.9 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.7B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Australian Super Pty LTD Portfolio

Follow Australian Super Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Australian Super Pty LTD with notifications on news.